Debasis Hazra

Title: Debasis Hazra: Innovator in Pharmaceutical Chemistry

Introduction

Debasis Hazra is a notable inventor based in Louisville, KY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of inhibitors that play a crucial role in cancer treatment.

Latest Patents

Debasis Hazra holds a patent for the "Synthesis of Mcl-1 inhibitor." This patent discloses intermediates and methods of synthesizing Compound 1, which is essential for advancing therapeutic options in oncology.

Career Highlights

Currently, Debasis Hazra is employed at AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on innovative solutions that address unmet medical needs, particularly in the area of cancer therapies.

Collaborations

Throughout his career, Debasis has collaborated with esteemed colleagues, including Craig Robert Stewart and Simon Hardy. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Debasis Hazra's contributions to pharmaceutical chemistry and his innovative work on Mcl-1 inhibitors highlight his importance in the field. His ongoing efforts at AstraZeneca AB continue to pave the way for advancements in cancer treatment.